Combating COVID-19 with the world’s first on-demand synthesis of the SARS-CoV-2 genome
Learn how Dr. Dan Gibson and team approached completing the world’s first on-demand synthesis of the SARS-CoV-2 genome — the causal agent of COVID-19 — using a commercially available, automated DNA assembly and cloning instrument — the BioXp™ system.
The webinar from April 30, 2020, explores the hierarchical assembly of the full-length synthetic SARS-CoV-2 genome and its potential applications.
Harnessing the power of the BioXp™ system to combat COVID-19 caused by SARS-CoV-2
Take a deeper look into how the BioXp™ system is enabling researchers around the world to rapidly synthesize SARS-CoV-2 genome parts and accelerate discovery pipelines.